Regadenoson is a Selective A2A Adenosine Receptor Agonist for Inflammation Research
It’s reported that iNKT cells are implicated in sickle cell disease (SCD), being both increased and activated in patients compared to controls. But iNKT cell depletion or activation blockage in…